MedTrace Logo

HSV Oral Reactivation in Children

NCT01878279 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2013-06-14

No results posted yet for this study

Summary

In the proposed study, the investigators will carry out novel research to evaluate both symptomatic and asymptomatic daily oral herpes simplex virus (HSV) shedding rates and copy number in children with and without HIV.

Study Objectives:

1. To evaluate the frequency of oral HSV reactivation in HIV-infected and uninfected children

Secondary Objectives:
2. To determine the acceptability of performing daily oral swabs in children age 3-12

Conditions

Interventions

OTHER

Underlying medical illness

Sponsors & Collaborators

  • Dartmouth-Hitchcock Medical Center

    lead OTHER

Principal Investigators

  • Richard Zuckerman, MD, MPH · Dartmouth-Hitchcock Medical Center

Eligibility

Min Age
3 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2010-07-31

Countries

  • Tanzania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01878279 on ClinicalTrials.gov